Drug Master Files for: nevirapine
✉ Email this page to a colleague
nevirapine Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
17782 | A | II | 10/26/2004 | HETERO LABS LTD | NEVIRAPINE |
17851 | A | II | 11/16/2004 | AUROBINDO PHARMA LTD | NEVIRAPINE ANHYDROUS USP |
17905 | A | II | 12/17/2004 | CIPLA LTD | NEVIRAPINE USP |
17915 | A | II | 12/16/2004 | MYLAN LABORATORIES LTD | NEVIRAPINE USP (ANHYDROUS) |
18401 | A | II | 5/22/2005 | AUROBINDO PHARMA LTD | NEVIRAPINE HEMIHYDRATE USP |
18576 | A | II | 7/30/2005 | AUROBINDO PHARMA LTD | NEVIRAPINE ANHYDROUS USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information